Discontinuation of the United States Medical Licensing Examination (USMLE)Step 2 Clinical Skills (CS) exam and Comprehensive Osteopathic Medical Licensing Examination (COMLEX) Level 2 Performance Evaluation (2-PE) raised questions about the ability of medical schools to ensure the clinical skills competence of graduating students. In February 2021, representatives from all Florida, United States, allopathic and osteopathic schools initiated a collaboration to address this critically important issue in the evolving landscape of medical education. A 5-point Likert scale survey of all members (n=18/20 individuals representing 10/10 institutions) reveals that initial interest in joining the collaboration was high among both individuals (mean 4.78, SD 0.43) and institutions (mean 4.69, SD 0.48). Most individuals (mean 4.78, SD 0.55) and institutions (mean 4.53, SD 0.72) are highly satisfied with their decision to join. Members most commonly cited a "desire to establish a shared assessment in place of Step 2 CS/2-PE" as their most important reason for joining. Experienced benefits of membership were ranked as the following: 1) Networking, 2) Shared resources for curriculum implementation, 3) Scholarship, and 4) Work towards a shared assessment in place of Step 2 CS/2-PE. Challenges of membership were ranked as the following: 1) Logistics such as scheduling and technology, 2) Agreement on common goals, 3) Total time commitment, and 4) Large group size. Members cited the "administration of a joint assessment pilot" as the highest priority for the coming year. Florida has successfully launched a regional consortium for the assessment of clinical skills competency with high levels of member satisfaction which may serve as a model for future regional consortia.
Objective: Total plaque area (TPA) has been associated with stroke risk factors; however, it has not been well studied in a Native American population. The objective of this study is to examine the relationship of TPA with stroke risk factors (RF). Methods: Participants enrolled in the “Stroke Prevention in the Wisconsin Native American Population” (n=119) underwent a health history risk assessment, cognitive testing, carotid ultrasound to measure TPA, and a meeting with a health wellness coach. TPA for each participant was measured using the LifeQ Medical Plaque Analysis Software (Nicosia, Cyprus). Statistical analyses were performed using SPSS (SPSS, IBM Corporation, Armonk, NY, USA) and SAS (SAS Institute Inc., Cary, NC, USA). Descriptive statistics for continuous variables are reported as the median and interquartile range (IQR). Spearman rho correlation was used to examine relationships between total plaque area and stroke risk factors. Robust M—estimation was used to examine which risk factors predicted TPA after adjustment for other covariates. Results: Of the 119 participants, 22 (18.5%) had no plaque and 97 (81.5%) had plaque, 100 (83.3%) were identified as high-risk (≥55 years with three risk factors for stroke) and 19 (15.8%) low-risk (≥55 years with fewer than three risk factors for stroke). Median participant age was 65 (IQR=11.0) years of age, 78.3% female. In univariate analyses, TPA was significantly associated with age (r s =.259;p=.005) and body mass index (BMI) (r s =-.300;p<.001). In a multivariable robust M-estimation model (including age, sex, BMI, systolic and diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, hemoglobin A1c, physical activity, and categorical variables (yes/no) current smoker, history of high cholesterol, coronary artery disease, diabetes, hypertension, and transient ischemic attack), only age (p=.03), sex (p=.012), and hemoglobin A1c (p=.028) remained significant for predicting total plaque area (r 2 =16.5%). Conclusion: Multivariate analysis demonstrated that age, sex, and hemoglobin A1c predicted TPA. Further work is needed to understand how both traditional and non-traditional stroke RFs may affect the risk of stroke in Native Americans.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.